(Q36802688)

16 August 2017

1 reference

title

Neoadjuvant use of endocrine therapy in breast cancer (English)

1 reference

16 August 2017

E Jane Macaskill

1

1 reference

16 August 2017

J Michael Dixon

series ordinal

2

1 reference

16 August 2017

publication date

1 May 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

13

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

243-250

1 reference

Chemotherapy before and after mastectomy in stage III breast cancer

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00417.X

Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00417.X

Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00417.X

Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00417.X

Letrozole as primary medical therapy for locally advanced and large operable breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00417.X

Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00417.X

Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00417.X

Long-term follow-up of elderly patients with locoregional breast cancer treated with tamoxifen only

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00417.X

Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00417.X

Anastrozole demonstrates clinical and biological effectiveness in oestrogen receptor-positive breast cancers, irrespective of the erbB2 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00417.X

10.1111/J.1524-4741.2007.00417.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference